Conditioning regimens for HSCT for patients with high-risk myelodysplastic syndrome and secondary acute myeloid leukaemia

被引：0
|
作者：
Zhang, Xi [1 ,2 ]
机构：
[1] Army Med Univ, Xinqiao Hosp, Med Ctr Hematol, State Key Lab Trauma Burn & Combined Injury, Chongqing, Peoples R China
[2] Jinfeng Lab, Chongqing, Peoples R China
来源：
LANCET HAEMATOLOGY | 2023年 / 10卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：e159 / e160
页数：2
相关论文
共 50 条
  • [1] Eltrombopag in patients with high-risk myelodysplastic syndrome or acute myeloid leukaemia: cautious optimism
    Buckstein, Rena
    LANCET HAEMATOLOGY, 2015, 2 (10): : E396 - E397
  • [2] Intensive treatment strategies in patients with high-risk myelodysplastic syndrome and secondary acute myeloid leukemia
    Oosterveld, M
    de Witte, T
    BLOOD REVIEWS, 2000, 14 (04) : 182 - 189
  • [3] Intensive treatment in patients with high-risk myelodysplastic syndromes and secondary acute leukaemia
    Bargay, J
    Brunet, S
    Esteve, J
    Ribera, J
    Ribera, J
    Llorente, A
    Marti, J
    Sarrà, J
    Guardia, R
    Pedro, C
    Nomdedeu, B
    Sierra, J
    Besalduch, J
    BONE MARROW TRANSPLANTATION, 2004, 33 : S256 - S256
  • [4] Early discontinuation of empirical antibiotic treatment in neutropenic patients with acute myeloid leukaemia and high-risk myelodysplastic syndrome
    Niessen, F. A.
    van Mourik, M. S. M.
    Bruns, A. H. W.
    Raijmakers, R. A. P.
    de Groot, M. C. H.
    van der Bruggen, T.
    ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL, 2020, 9 (01)
  • [5] Early discontinuation of empirical antibiotic treatment in neutropenic patients with acute myeloid leukaemia and high-risk myelodysplastic syndrome
    F. A. Niessen
    M. S. M. van Mourik
    A. H. W. Bruns
    R. A. P. Raijmakers
    M. C. H. de Groot
    T. van der Bruggen
    Antimicrobial Resistance & Infection Control, 9
  • [6] Low-Dose Decitabine Combined with Modified Bucy Is More Effective Conditioning Regimen for High-Risk Patients with Acute Myeloid Leukaemia/Myelodysplastic Syndrome
    Tang, Xiaowen
    Cao, Jing
    Shi, Xiaojing
    Ge, Ling
    Sun, Aining
    Zhu, Xiaming
    Qiu, Huiying
    Jin, Zhengming
    Miao, Miao
    Fu, Chengcheng
    Ma, Xiao
    Chen, Feng
    Xue, Shengli
    Han, Yue
    Xue, Mengxing
    Mao, Xinliang
    Wu, Depei
    BLOOD, 2016, 128 (22)
  • [7] Effect of invasive aspergillosis on risk for different causes of death in older patients with acute myeloid leukaemia or high-risk myelodysplastic syndrome
    Rebecca van Grootveld
    Valentina Masarotto
    Peter A. von dem Borne
    Nicole M. A. Blijlevens
    Dana A. Chitu
    Martha T. van der Beek
    Marta Fiocco
    Mark G. J. de Boer
    BMC Infectious Diseases, 23
  • [8] Effect of invasive aspergillosis on risk for different causes of death in older patients with acute myeloid leukaemia or high-risk myelodysplastic syndrome
    van Grootveld, Rebecca
    Masarotto, Valentina
    von dem Borne, Peter A.
    Blijlevens, Nicole M. A.
    Chitu, Dana A.
    van der Beek, Martha T.
    Fiocco, Marta
    de Boer, Mark G. J.
    BMC INFECTIOUS DISEASES, 2023, 23 (01)
  • [9] Prospective feasibility analysis of reduced-intensity conditioning (RIC) regimens for hematopoietic stem cell transplantation (HSCT) in elderly patients with acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (MDS)
    Estey, Elihu
    de Lima, Marcos
    Tibes, Raoul
    Pierce, Sherry
    Kantarjian, Hagop
    Champlin, Richard
    Giralt, Sergio
    BLOOD, 2007, 109 (04) : 1395 - 1400
  • [10] Bone marrow mononuclear cell telomere length in acute myeloid leukaemia and high-risk myelodysplastic syndrome
    Warny, Marie
    Helby, Jens
    Sengelov, Henrik
    Nordestgaard, Borge G.
    Birgens, Henrik
    Bojesen, Stig E.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2019, 102 (03) : 218 - 226
12345